The impact of immunization on the number of hospitalization due to Covid at the federal scope, in the state of Rio de Janeiro and in the municipality of Valença (RJ)
DOI:
https://doi.org/10.24859/SaberDigital.2023v16n02.1428Keywords:
Covid, Vaccination, HospitalizationAbstract
Introduction. COVID-19 is a contagious infectious disease of great magnitude for public health in the world, since it has generated a collapse of the health system in several countries. Objective. The objective of the study is to analyze the number of hospitalizations, cases, deaths and the vaccination coverage rate for COVID-19 in Brazil, in the state of Rio de Janeiro and in the municipality of Valença-RJ. Material and methods. This is a retrospective, descriptive study, with quantitative analysis, using data obtained through national database systems from February 2020 to July 2022. Results and discussion. At the end of the data collection period the vaccination rate in Brazil was 84.1% with the first dose, 79.1% with the complete vaccination schedule, 47.2% with the booster dose, and a total of 678,514 deaths were reported. In the state of Rio de Janeiro, 79.1% with the first dose, 73.7% with the complete vaccination schedule, 39.9% with the booster dose and 74,766 deaths from COVID-19 and 187,959 SARS (Severe Acute Respiratory Syndrome) hospitalizations due to COVID-19. In Valença-RJ, 83.3% with the first dose, 80.8% with the complete vaccination schedule, 50.9% with a booster dose and 240 deaths from COVID-19 and 1,022 SARS hospitalizations due to COVID-19. Conclusion. The COVID-19 pandemic was overwhelming not only in the biomedical and epidemiological order, but also generating socioeconomic, cultural, political and historical impacts. Control of mortality and hospitalization was due to good vaccination coverage. It is worth emphasizing the importance of maintaining vaccination.
Downloads
References
ANESI GL, Jablonski J, Harhay MO, et al. Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United States. Ann Intern Med. 2021;174(5):613-621. doi:10.7326/M20-5327. DOI: https://doi.org/10.7326/M20-5327
ANVISA (Brasil). Vacinas. Brasília, 2022. Disponível em: https://www.gov.br/anvisa/pt- br/assuntos/paf/coronavirus/vacinas. Acesso em: 11 fev. 2022.
BRASIL, Ministério da Saúde (Brasil). Biblioteca Virtual em Saúde. Novo Coronavírus (Covid-19): informações básicas. 2020. Disponível em: https://bvsms.saude.gov.br/novo- coronavirus-covid-19-informacoes-basicas/. Acesso em: 11 fev. 2022.
BRASIL, Ministério da Saúde (BRASIL). UNA-SUS. Organização Mundial de Saúde declara pandemia do novo Coronavírus: Mudança de classificação obriga países a tomarem atitudes preventivas. JORNAL UNA-SUS, Brasília, 11 mar. 2020. Disponível em: https://www.unasus.gov.br/noticia/organizacao-mundial-de-saude-declara-pandemia-de-coronavirus. Acesso em: 11 fev. 2022.
CATES J, Lucero-Obusan C, Dahl RM, et al. Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(42):1528-1534. Published 2020 Oct 23. doi:10.15585/mmwr.mm6942e3 DOI: https://doi.org/10.15585/mmwr.mm6942e3
CORMAN VM, Muth D, Niemeyer D, et al. Hosts and sources of endemic human coronaviruses. Adv Virus Res. 2018;100:163–188. Crossref. PubMed. DOI: https://doi.org/10.1016/bs.aivir.2018.01.001
CUMMINGS MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395(10239):1763-1770. doi:10.1016/S0140-6736(20)31189-2 DOI: https://doi.org/10.1016/S0140-6736(20)31189-2
FERNANDES, M.; MATTA, G.; PAIVA, E., 2022. COVID-19, Vaccine Hesitancy and Child Vaccination: Challenges from Brazil. Lancet Reg. Health-Am. 2022, 8, 100246. DOI: https://doi.org/10.1016/j.lana.2022.100246
GARG S, Patel K, Pham H, et al. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020: A Cross-Sectional Study. Ann Intern Med. 2021;174(10):1409-1419. doi:10.7326/M21-1991 DOI: https://doi.org/10.7326/M21-1991
GRUPO GLOBO (org.). • GLOBO COMUNICAÇÃO E PARTICIPAÇÕES S.A. Brasil pode não ter agulhas e seringas suficientes para vacinar contra Covid, alerta conselho. Jornal Nacional. Dez 30, 2020.
https://g1.globo.com/jornalnacional/noticia/2020/12/30/brasil-pode-nao-ter-agulhas-e-seringassuficientespara-vacinar-contra-covid-alertaconselho.ghtml. Acesso em 23 de fevereiro de 2023.
GRUPO GLOBO (org.). • GLOBO COMUNICAÇÃO E PARTICIPAÇÕES S.A.: mapa da vacinação contra covid-19 no brasil.. Mapa da vacinação contra Covid-19 no Brasil.. 2022. Mapa da vacinação contra Covid-19 no Brasil.. Disponível em: https://especiais.g1.globo.com/bemestar/vacina/2021/mapa-brasil-vacina-covid/. Acesso em: 20 out. 2022.
HALLAL PC. SOS Brazil: science under attack. Lancet 2021; 397(10272):373-374.) DOI: https://doi.org/10.1016/S0140-6736(21)00141-0
HORWITZ LI, Jones SA, Cerfolio RJ, et al. Trends in COVID-19 Risk-Adjusted Mortality Rates. J Hosp Med. 2021;16(2):90-92. doi:10.12788/jhm.3552 DOI: https://doi.org/10.12788/jhm.3552
HUI DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019;33(4):869–889. Crossref. PubMed. IBGE (Brasil). Cidades e Estados: Brasil. 2021. Disponível em: https://www.ibge.gov.br/cidades-e-estados. Acesso em: 12 fev. 2022. DOI: https://doi.org/10.1016/j.idc.2019.07.001
JOHNS HOPKINS UNIVERSITY (Estados Unidos da América) (org.). Coronavirus Resource Center: COVID-19 Dashboard. In: Coronavirus Resource Center: COVID-19 Dashboard: coronavirus resource center: covid-19. Coronavirus Resource Center: COVID-19. 2022. Dashboard. Disponível em: https://coronavirus.jhu.edu/map.html. Acesso em: 17 nov. 2022.
LEWNARD JA, Liu VX, Jackson ML, et al. Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study [published correction appears in BMJ. 2020 Jun 4;369:m2205]. BMJ. 2020;369:m1923. Published 2020 May 22. doi:10.1136/bmj.m1923 DOI: https://doi.org/10.1136/bmj.m1923
LOTTA,G., ET AL. COVID-19 Vaccination Challenge: What Have We Learned from the Brazilian Process? Lancet Glob. Health 2022, 10, e613–e614. DOI: https://doi.org/10.1016/S2214-109X(22)00049-3
OUR WORLD IN DATA. Coronavirus (COVID-19): Coronavirus (COVID-19) Deaths. Coronavirus Pandemic (COVID-19), 2022. Disponível em: https://ourworldindata.org/covid-deaths?country=~OWID_WRL#citation. Acesso em: 11 fev. 2022.
PEIRIS M, LEUNG GM. What can we expect from first-generation COVID-19 vaccines? Lancet. 2020; 396: 1467–69. DOI: https://doi.org/10.1016/S0140-6736(20)31976-0
PETRILLI CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. Published 2020 May 22. doi:10.1136/bmj.m1966 DOI: https://doi.org/10.1136/bmj.m1966
RICHARDSON S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [published correction appears in JAMA. 2020 May 26;323(20):2098]. JAMA. 2020;323(20):2052-2059.
doi:10.1001/jama.2020.6775 DOI: https://doi.org/10.1001/jama.2020.6775
SALES-MIOLI, A.I.L.; GALVÃO-LIMA, L.J, PINTO, T.K.B; CARDOSO, P.H; SILVA, R.D; FERNANDES, F; BARBALHO, I.M.P; FARIAS, F.L.O; VERAS, N.V.R; SOUZA, G.F, ET. Effectiveness of COVID-19 Vaccination on Reduction of Hospitalizations and Deaths in Elderly Patients in Rio Grande do Norte, Brazil. Int. J. Environ. Res. Public Health 2022, 19, 13902. https://doi.org/10.3390/ ijerph192113902 DOI: https://doi.org/10.3390/ijerph192113902
SECRETARIA DE SAÚDE DO ESTADO DO RIO DE JANEIRO. PAINEL CORONAVÍRUS COVID-19. Rio de Janeiro, 2022. Disponível em: https://painel.saude.rj.gov.br/monitoramento/covid19.html. Acesso em: 29 out. 2022. (1)
SERPA FS, et al. Vacinas COVID-19 e imunobiológicos. Arq Asma Alerg Imunol. 2021;5(2):126-134
SIVEP-GRIPE. (org.) Rio de Janeiro. Notificações de Síndromes Respiratórias Agudas Graves (SRAG): sivep_gripe. SIVEP_GRIPE. 2022. SECRETARIA ESTADUAL DE SAÚDE. Disponível em: http://sistemas.saude.rj.gov.br/tabnetbd/dhx.exe?sivep_gripe/sivep_gripe.def. Acesso em: 03 nov. 2022.
VERMA AA, Hora T, Jung HY, et al. Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area. CMAJ. 2021;193(12):E410-E418. doi:10.1503/cmaj.202795 DOI: https://doi.org/10.1503/cmaj.202795
WANG C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–473. Crossref. PubMed. DOI: https://doi.org/10.1016/S0140-6736(20)30185-9
WU F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265–269. Crossref. PubMed. DOI: https://doi.org/10.1038/s41586-020-2008-3
XIE Y, Bowe B, Maddukuri G, Al-Aly Z. Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study. BMJ. 2020;371:m4677. Published 2020 Dec 15. doi:10.1136/bmj.m4677 DOI: https://doi.org/10.1136/bmj.m4677
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pedro Mantovani Spínola, Willy Muri Thompson Jr , Yan Fernandes Thompson , Cíntia Valéria Galdino , Tiago Cunha Berno Campos , Nathan Caulo Raymundo, Bernardo Acácio Daibes, Arthur Pereira da Silva Catharino
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Declaração de Direito Autoral
Autores que publicam na Revista Saber Digital concordam com os seguintes termos:
Os autores mantêm os direitos e cedem à revista o direito à primeira publicação, simultaneamente submetido a uma licença Creative Commons que permite o compartilhamento por terceiros com a devida menção ao autor e à primeira publicação pela Revista Saber Digital.
Os autores podem entrar em acordos contratuais adicionais e separados para a distribuição não exclusiva da versão publicada da obra (por exemplo, postá-la em um repositório institucional ou publicá-la em um livro), com o reconhecimento de sua publicação inicial na Revista Saber Digital.
Este obra está licenciado com uma Licença https://creativecommons.org/licenses/by-nc/4.0/
